Reducing levels of nicotinic alkaloids in plants

US10076134B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10076134-B2
Application numberUS-201715828875-A
CountryUS
Kind codeB2
Filing dateDec 1, 2017
Priority dateFeb 28, 2005
Publication dateSep 18, 2018
Grant dateSep 18, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Two genes, A622 and NBB1, can be influenced to achieve a decrease of nicotinic alkaloid levels in plants. In particular, suppression of one or both of A622 and NBB1 may be used to decrease nicotine in tobacco plants.

First claim

Opening claim text (preview).

What is claimed is: 1. A tobacco plant comprising plant cells into which one or more mutations are introduced into the region of SEQ ID NO: 3 that encodes a polypeptide having the amino acid sequence set forth in SEQ ID NO: 4, wherein the plant exhibits reduced expression of a gene product encoded by SEQ ID NO: 3 as compared to a control tobacco plant. 2. The tobacco plant of claim 1 , wherein the tobacco plant exhibits a reduced nicotine level as compared to a control tobacco plant. 3. Seeds from or a progeny plant of the tobacco plant of claim 1 , wherein the seeds or progeny plant comprise in their genomes the one or more mutations. 4. A product comprising the plant of claim 2 , and having a reduced level of nicotine as compared to a product produced from a control plant, wherein the product is selected from the group consisting of a tobacco product, food product, food ingredient, feed product, feed ingredient, nutritional supplement, and biofuel. 5. The tobacco product of claim 4 , wherein the product is selected from the group consisting of smoking cessation products, cigarettes, cigarette tobacco, cigars, cigar tobacco, snus, pipe tobacco, and chewing tobacco.

Assignees

Inventors

Classifications

  • Nicotine · CPC title

  • Flakes or shreds of tobacco · CPC title

  • Cigars; Cigarettes · CPC title

  • Antisense, co-suppression, viral induced gene silencing [VIGS], post-transcriptional induced gene silencing [PTGS] · CPC title

  • Tobacco for pipes, for cigars, e.g. cigar inserts, or for cigarettes; Chewing tobacco; Snuff (reconstituted tobacco products A24B3/14) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10076134B2 cover?
Two genes, A622 and NBB1, can be influenced to achieve a decrease of nicotinic alkaloid levels in plants. In particular, suppression of one or both of A622 and NBB1 may be used to decrease nicotine in tobacco plants.
Who is the assignee on this patent?
22Nd Century Ltd Llc
What technology area does this patent fall under?
Primary CPC classification C12N15/8243. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Sep 18 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).